Federica Genovese

12PUBLICATIONS
41CO-AUTHORS
Molecular targetsAutonomic nervous systemCancer diagnosisChemical and thermal processes in energy and combustionCatalysis and mechanisms of reactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 17, 2026
Combination therapy of RAS inhibition and glucagon-like peptide-1 receptor agonist improves a marker of kidney fibrosis in people with type 2 diabetes.

|Dec 09, 2025
Endotrophin as a biomarker and mediator in cardiovascular-kidney-metabolic syndrome: current insights and remaining questions.

Federica Genovese, Morten Karsdal, Hanne Devos

|Mar 27, 2025
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics.

Morten Karsdal, Thomas R Cox, Amelia L Parker

|Feb 10, 2025
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury.

Nadja Sparding, Federica Genovese, Morten Asser Karsdal

|Jul 16, 2024
Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis.

Daniel G K Rasmussen, Michael K Hansen, Peder Frederiksen

|Nov 25, 2023
Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.

Alexandra Louise Møller, Stefanie Thöni, Felix Keller

Pageof 2

Frequent Collaborators

4 joint publications

Morten Karsdal

3 joint publications

Nadja Sparding

2 joint publications

Felix Keller

2 joint publications

Alexandra Louise Møller